FLORA software: semi-automatic LGE-CMR analysis tool for cardiac lesions identification and characterization
- PMID: 35435606
- DOI: 10.1007/s11547-022-01491-8
FLORA software: semi-automatic LGE-CMR analysis tool for cardiac lesions identification and characterization
Abstract
Purpose: Today there is a growing interest in the quantification of late gadolinium enhancement (LGE) in ischemic and non-ischemic cardiac pathologies. We build an automatic self-made free software FLORA (For Late gadOlinium enhanced aReas clAssification) for the recognition, classification and quantification of LGE areas that allows to improve the observer's performances and that homogenizes the evaluations between different operators.
Material and methods: We have retrospectively selected 120 CMR exams: 40-ischemic with evident scar tissue on LGE sequences; 40-non-ischemic cardiomyopathy; 40-any myocardial alteration on CMR, especially on LGE sequences. FLORA's performance was compared to the radiologist's evaluation.
Results: FLORA identified both ischemic and non-ischemic myocardial lesions in almost all cases (80/80 and 79/80 for the double-Gaussian fit method and fixed-shift method, respectively, with sensitivity and specificity of 100%/98.8% and 55%/50%, respectively). The best results were obtained from the classification of ischemic myocardial damage, which was correctly identified in 85%-95% of cases. FLORA also increases the agreement between observers and allows a quantitative evaluation of transmurality.
Conclusions: FLORA has proven to be an applicable tool that improves and facilitates the classification of LGE areas allowing their quantification.
Keywords: Cardiac radiology; Ischemic cardiomyopathies; Late gadolinium enhancement (LGE); Magnetic resonance imaging (MRI); Non-ischemic cardiomyopathies; Quantification software.
© 2022. Italian Society of Medical Radiology.
References
-
- Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43(12):2260–2264. https://doi.org/10.1016/j.jacc.2004.03.035 - DOI - PubMed
-
- Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100(19):1992–2002. https://doi.org/10.1161/01.cir.100.19.1992 - DOI - PubMed
-
- Pradella S, Grazzini G, De Amicis C, Letteriello M, Acquafresca M, Miele V (2020) Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies. Radiol Med 125(11):1056–1071. https://doi.org/10.1007/s11547-020-01276-x - DOI - PubMed
-
- Becker M, Cornel JH, van de Ven PM, van Rossum AC, Allaart CP, Germans T (2018) The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis. JACC JACC Cardiovasc Imaging 11(9):1274–1284. https://doi.org/10.1016/j.jcmg.2018.03.006 - DOI - PubMed
-
- Esposito A, Gallone G, Palmisano A, Marchitelli L, Catapano F, Francone M (2020) The current landscape of imaging recommendations in cardiovascular clinical guidelines: toward an imaging-guided precision medicine. Radiol Med 125(11):1013–1023. https://doi.org/10.1007/s11547-020-01286-9 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
